As you plan your agenda for ISCT, be sure to add our live and on-demand events to your calendar, featuring learnings and experiences from your peers about how they optimized their processes to move from research and development to commercial scale.
Live Symposium 28 May, 10:00 a.m. ET
The Development Trend and Clinical Application of Novel Automated CAR T-Cell Expansion Technology
Dr. Yu Lei, PhD, CEO and co-founder, Unicar-Therapy Bio-Medicine Technology Co., Ltd., Shanghai
The preparation of high-quality and reliable CAR T cells is one of the key factors of CAR T drug formation. While traditional CAR T-cell preparation technology has been unable to meet the needs of clinical treatment, the presenters will describe how they’re leveraging automated expansion technology to produce CAR T cells that can improve anti-tumor efficacy, reduce recurrence and improve safety.
Visit the ISCT event site to add to your calendar.
Live Industry Expert Roundtable 26 May, 12:30 p.m. ET
Successes and Failures Managing Clinical Trials in Apheresis Centers
Join us for a live panel discussion moderated by Dr. Joseph (Yossi) Schwartz, director of the Division of Transfusion Medicine and Cell Therapy at Weill Cornell Medicine, including industry experts who will share their viewpoints on the cell collection ecosystems across key clinical trial and cell collection stakeholders.
Industry experts from UC Health and Stafa Cellular Therapy will share their viewpoints on:
Manufacturing failures and causes at collection sites
Suggested methods for tracking data and their successes
Recommended approaches for ensuring communication between manufacturers and collection sites
Proven process improvement strategies
Don’t miss this informal and transparent discussion, which will tap into the cell collection ecosystems across key clinical trial and cell collection stakeholders.
Visit the ISCT event site to add to your calendar.
Visit the Poster Hall to Learn More and Engage With Presenters
The Monoculture of Cord-Blood-Derived CD34+ Cells by Perfusion Using a Semi-Permeable Hollow-Fiber-Membrane Quantum® Cell Expansion System With a Novel Growth Factor Cocktail
Health Economic Evaluation of Fill and Finish in Cell and Gene Therapy Manufacturing